semaglutide madison Washingtonians share how they afford pricey weight loss medications Jacqueline Kirby Zonkowski | Just

The GLP-1 component provides the foundation of weight loss activity that has proven effective across multiple approved medications

Cutting or crushing the tablet would: Disrupt the specialized coating and formulation designed for gastric absorption Potentially alter the pharmacokinetic profile, leading to unpredictable drug levels Reduce bioavailability, as oral semaglutide already has low absorption (approximately 1% bioavailability per FDA labeling) Create inconsistent dosing between the two halves Expose the patient to medication that may not be absorbed effectively The American Diabetes Association guidelines emphasize that medications should be taken as prescribed and formulated unless specifically indicated otherwise by the manufacturer

Compounded semaglutide uses the same active ingredient but is prepared by a compounding pharmacy rather than manufactured by Novo Nordisk

Clinical trial results (STEP trials): Average weight loss: 15-17% of body weight At 68 weeks on 2.4mg dose: 33 pounds for a 200-pound person 86% of participants lost at least 5% body weight 50% lost at least 15% body weight This is pharmaceutical-grade weight loss

At 68 weeks, the semaglutide group lost an average 14.9% of body weight vs 2.4% on placebo